Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Coronary revascularization

Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002 346 1773-1780. [Pg.201]

Gropler RJ, Geltman EM, Sampathkumaran K, Perez JE, Moerlein SM, Sobel BE et al. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol 1992 20 569-577... [Pg.34]

Gould KL. Does positron emission tomography improve patient selection for coronary revascularization J Am Colt Cardiol 1992 20 566-568... [Pg.35]

The Role of Percutaneous Coronary Revascularization in Advanced Ischemic Heart Disease... [Pg.69]

Left ventricular hypertrophy Angina or prior myocardial infarction Prior coronary revascularization Heart failure... [Pg.572]

Basically, the medical therapy that was required to control ischemia during the hospital stay will have to be continued after discharge from the hospital. If the patient did not undergo coronary revascularization, revascularization was unsuccessful or had recurrent symptom after revascularization, the medical therapy will have to be same. [Pg.589]

Topol EJ, Moliterno DJ, Hermann HC, Powers ER, et al. 2001. Comparison of two platelet glycoproteins Ilb/IIIa inhibitors, Tirofiban and abciximab, for the prevention of ischemic events with precutaneous coronary revascularization. NEJM. 344 1888-1894. [Pg.126]

Wiviott SD, Braunwald E. Unstable angina and non-ST-segment elevation myocardial infarction part II. Coronary revascularization, hospital discharge, and post-hospital care. Am Fam Physician. 2004 70 535-538. [Pg.319]

Burzotta F, Iacoviello L, Di Castelnuovo A, et al. Relation of the-174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol 2001 88 1125-1128. [Pg.209]

I I The EPILOG Investigators. Platelet glycoprotein llb/llla receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997 ... [Pg.55]

Topol EJ, Lincoff AM, Kereiakes DJ, et al, Multi-year follow-up of abciximab therapy in three randomized, palcebo-controlled trials of percutaneous coronary revascularization, Am J Med 2002 I 13 1-6. [Pg.56]

Lincoff AM, Kleiman NS, Kereiakes DJ, et al, REPLACE-2 investigators, Long-term efficacy of bivalirudin and provisional glycoprotein llb/llla blockade vs heparin and planned glycoprotein llb/llla blockade during percutaneous coronary revascularization, JAMA 2004 292 696-703,... [Pg.56]

Jackson JD, Muhlestein JB, Bunch TJ. (3-Blockers reduce the incidence of clinical restenosis Prospective study of 4840 patients undergoing percutaneous coronary revascularization Am Heart J 2003 145 875-881. [Pg.194]

Inclusion criteria were similar to our previous pilot study (34), Patients with clinical indication of percutaneous coronary revascularization were randomized if they had a de novo severe stenosis in a native coronary artery, a lesion suitable for stent, and a reference vessel size between 2.5 and 4.0 by visual estimation, and were a candidate for coronary bypass surgery, All the PCI procedures were performed at the Catheterization Laboratories at Otamendi Hospital and Sanatorio Las Lomas in Buenos Aires, Argentina. [Pg.201]

Serruys PW, Ormiston JA, Sianos G, et al, Actinomycin-eluting stent for coronary revascularization a randomized feasibility and safety study the ACTION trial, J Am Coll Cardiol 2004 44(7)4 363-1367. [Pg.261]

Grube E, Lansky A, Hauptmann KE, et al. High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization one-year results from the SCORE randomized trial. J Am Coll Cardiol 2004 44(7) 1368-1372. [Pg.264]

Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005 112(14) ... [Pg.265]

Windecker S, RemondinoA, Eberli FR, etal, Sirolimus-eluting and paditaxeI-eIuting stents for coronary revascularization. N Engl J Med 2005 353(7) 653-662. [Pg.361]

See other pages where Coronary revascularization is mentioned: [Pg.81]    [Pg.101]    [Pg.154]    [Pg.270]    [Pg.71]    [Pg.73]    [Pg.75]    [Pg.77]    [Pg.79]    [Pg.81]    [Pg.83]    [Pg.54]    [Pg.589]    [Pg.63]    [Pg.160]    [Pg.162]    [Pg.164]    [Pg.323]    [Pg.479]   
See also in sourсe #XX -- [ Pg.188 , Pg.189 ]



SEARCH



Revascularization

Should We Emergently Revascularize Occluded Coronaries for

© 2024 chempedia.info